JP2007509844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509844A5 JP2007509844A5 JP2006530223A JP2006530223A JP2007509844A5 JP 2007509844 A5 JP2007509844 A5 JP 2007509844A5 JP 2006530223 A JP2006530223 A JP 2006530223A JP 2006530223 A JP2006530223 A JP 2006530223A JP 2007509844 A5 JP2007509844 A5 JP 2007509844A5
- Authority
- JP
- Japan
- Prior art keywords
- microcapsule
- polymer
- water
- active ingredient
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000654 additive Substances 0.000 claims description 14
- 230000000996 additive effect Effects 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229960005168 croscarmellose Drugs 0.000 claims description 2
- 229960000913 crospovidone Drugs 0.000 claims description 2
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 2
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 239000000391 magnesium silicate Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000003094 microcapsule Substances 0.000 claims 29
- 238000000034 method Methods 0.000 claims 18
- 239000004480 active ingredient Substances 0.000 claims 13
- 229920000642 polymer Polymers 0.000 claims 9
- 229920001688 coating polymer Polymers 0.000 claims 7
- 229920006254 polymer film Polymers 0.000 claims 7
- 239000002245 particle Substances 0.000 claims 4
- 238000005191 phase separation Methods 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 2
- 239000001856 Ethyl cellulose Substances 0.000 claims 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000005354 coacervation Methods 0.000 claims 2
- 229920001249 ethyl cellulose Polymers 0.000 claims 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 229920000881 Modified starch Polymers 0.000 claims 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000011247 coating layer Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 229940014259 gelatin Drugs 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 229910052919 magnesium silicate Inorganic materials 0.000 claims 1
- 235000019792 magnesium silicate Nutrition 0.000 claims 1
- 238000010979 pH adjustment Methods 0.000 claims 1
- 229920005597 polymer membrane Polymers 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 229920003176 water-insoluble polymer Polymers 0.000 claims 1
- 229920003169 water-soluble polymer Polymers 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001096A ITMI20031096A1 (it) | 2003-05-30 | 2003-05-30 | Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento |
| ITMI2003A001096 | 2003-05-30 | ||
| PCT/EP2004/050962 WO2004105725A2 (en) | 2003-05-30 | 2004-05-28 | Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509844A JP2007509844A (ja) | 2007-04-19 |
| JP2007509844A5 true JP2007509844A5 (enExample) | 2011-01-27 |
| JP4968829B2 JP4968829B2 (ja) | 2012-07-04 |
Family
ID=30131119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530223A Expired - Fee Related JP4968829B2 (ja) | 2003-05-30 | 2004-05-28 | コアセルベーションによりコーティングポリマーに導入された薬物を有するマイクロカプセル |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20070048385A1 (enExample) |
| EP (1) | EP1628640B1 (enExample) |
| JP (1) | JP4968829B2 (enExample) |
| AT (1) | ATE378041T1 (enExample) |
| DK (1) | DK1628640T3 (enExample) |
| ES (1) | ES2297439T3 (enExample) |
| IT (1) | ITMI20031096A1 (enExample) |
| PL (1) | PL1628640T3 (enExample) |
| WO (1) | WO2004105725A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101351680B1 (ko) * | 2007-03-22 | 2014-01-15 | 주식회사 엘지생활건강 | 마이크로 캡슐，그 제조방법 및 마이크로 캡슐을 포함하는기능성 조성물 |
| EP3003031A1 (en) | 2013-06-04 | 2016-04-13 | Vyome Biosciences Pvt Ltd | Coated particles and compositions comprising same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394287A (en) * | 1981-04-10 | 1983-07-19 | Eurand America, Inc. | Incorporation of finely divided additives at the surface of microcapsule walls |
| US4634587A (en) * | 1982-07-09 | 1987-01-06 | Key Pharmaceuticals, Inc. | Sustained release quinidine dosage form |
| US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
| JPS62135419A (ja) * | 1985-12-06 | 1987-06-18 | Ikeda Mohandou:Kk | ジクロフエナク塩の粒状組成物及びその製造法 |
| JPH0832625B2 (ja) * | 1987-01-29 | 1996-03-29 | 武田薬品工業株式会社 | 有核顆粒およびその製造法 |
| US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| US5252337A (en) * | 1991-06-25 | 1993-10-12 | Eurand America, Inc. | Controlled release calcium channel blocker microcapsules |
| EP0706794B1 (en) * | 1994-10-14 | 2001-12-12 | Japan Energy Corporation | Anti-aids pharmaceutical preparations and processes for the production thereof |
| DE19539361A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
| TR199802718T2 (xx) * | 1996-06-28 | 1999-03-22 | Schering Corporation | Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im. |
| FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
| UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| EP1072257A1 (en) * | 1998-04-17 | 2001-01-31 | Taisho Pharmaceutical Co., Ltd | Multiple-unit sustained release tablets |
| DE19930795A1 (de) * | 1999-07-03 | 2001-01-11 | Encapbiosystems Ag Schiers | Verfahren zur Verkapselung von Substanzen sowie Teilchen dafür |
-
2003
- 2003-05-30 IT IT001096A patent/ITMI20031096A1/it unknown
-
2004
- 2004-05-28 WO PCT/EP2004/050962 patent/WO2004105725A2/en not_active Ceased
- 2004-05-28 JP JP2006530223A patent/JP4968829B2/ja not_active Expired - Fee Related
- 2004-05-28 AT AT04741678T patent/ATE378041T1/de not_active IP Right Cessation
- 2004-05-28 EP EP04741678A patent/EP1628640B1/en not_active Expired - Lifetime
- 2004-05-28 US US10/558,948 patent/US20070048385A1/en not_active Abandoned
- 2004-05-28 ES ES04741678T patent/ES2297439T3/es not_active Expired - Lifetime
- 2004-05-28 PL PL04741678T patent/PL1628640T3/pl unknown
- 2004-05-28 DK DK04741678T patent/DK1628640T3/da active
-
2012
- 2012-11-20 US US13/681,727 patent/US20130156934A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3019235B2 (ja) | スフェロイド製剤 | |
| AU760006B2 (en) | Method for making granules with masked taste and instant release of the active particle | |
| JP4549442B2 (ja) | ミルナシプランの持続性放出を伴うガレヌス製剤形態 | |
| JP2013189481A (ja) | フリバンセリンの製剤及びその製造方法 | |
| JP3987282B2 (ja) | 粒状化結晶性イブプロフェンで被覆した粒子 | |
| JP2005538105A (ja) | 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法 | |
| JP2007511510A (ja) | 持続放出性ベンラファキシン製剤 | |
| JP3017040B2 (ja) | トリメタジジンの経口投与用持続的放出型薬剤組成物 | |
| JP4234427B2 (ja) | 活性成分をベースとする微小顆粒およびその製造方法 | |
| JP2009537611A5 (ja) | リポ酸のペレット | |
| US20090017111A1 (en) | Tolterodine bead | |
| JP2000212075A (ja) | 貯蔵安定な放出様相を有する徐放性トラマド―ル調合物及びその製造方法 | |
| EP2740471B1 (en) | Oral pharmaceutical composition comprising dabigatran etexilate | |
| WO2007122015A1 (en) | Tolterodine beads | |
| WO2005102269A2 (en) | An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production | |
| JP2002515423A5 (enExample) | ||
| WO2005120468A1 (en) | Multi-layered controlled-release methylphenidate pellet | |
| JP2007509844A5 (enExample) | ||
| US20080081067A1 (en) | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof | |
| JP4968829B2 (ja) | コアセルベーションによりコーティングポリマーに導入された薬物を有するマイクロカプセル | |
| JP2008520696A5 (enExample) | ||
| RU2727721C2 (ru) | Фармацевтическая композиция с замедленным высвобождением, содержащая ривастигмин | |
| KR20100130882A (ko) | 서방성 비스테로이드성 소염제 조성물 및 그 제조방법 | |
| AU2017339247B2 (en) | Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof | |
| GB2258613A (en) | Pharmaceutical diltiazem spheroid formulation |